PerspectiveStem Cells

Marketing of unproven stem cell–based interventions: A call to action

See allHide authors and affiliations

Science Translational Medicine  05 Jul 2017:
Vol. 9, Issue 397, eaag0426
DOI: 10.1126/scitranslmed.aag0426

You are currently viewing the abstract.

View Full Text


Commercial promotion of unsupported therapeutic uses of stem cells is a global problem that has proven resistant to regulatory efforts. Here, we suggest a coordinated approach at the national and international levels focused on engagement, harmonization, and enforcement to reduce the risks associated with direct-to-consumer marketing of unproven stem cell treatments.

This is an article distributed under the terms of the Science Journals Default License.

View Full Text